Screener
Journey Medical Corporation DERM Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 65.5%-4.0pp | 65.4%-1.0pp | 66.2%+3.4pp | 70.2%+6.3pp | 69.4%-2.2pp | |
| Operating margin | -4.4%— | -9.8%— | -13.2%— | —— | —— | |
| Net margin | -9%— | -14.8%— | -18.5%— | —— | —— | |
| Returns | ||||||
| Return on equity | -23.8%— | -36.6%— | -44%— | —— | —— | |
| Return on invested capital | -10.7%— | -23.2%— | -28.2%— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.8×0.0× | 0.7×0.0× | 0.7×0.0× | 0.8×-0.1× | 0.8×-0.4× | |
| Liquidity | ||||||
| Current ratio | 1.6×+0.3× | 1.7×+0.4× | 1.8×+0.4× | 1.4×0.0× | 1.3×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.8×-0.5× | 0.8×-0.3× | 0.8×-0.5× | 1×-0.8× | 1.3×-0.4× | |
| Net debt / EBITDA | -0.1×— | —— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $1.17+41.4% | $1.13+18.5% | $1.30+32.4% | $1.04+95.0% | $0.83+46.3% | |
| Valuation | ||||||
| Market capitalization | $212.95M+16.8% | $128.18M-6.0% | $209.22M+156% | $187.33M+65.8% | $148.63M+33.4% | |
| Price / sales | 3.1×-0.1× | 2×-0.4× | 3.4×+1.9× | 3.2×+1.2× | 2.6×+1.2× | |
| Price / book | 6.6×-2.8× | 4.2×-2.2× | 6.6×+2.5× | 7.2×-3.1× | 7.7×-2.1× | |
| EV / EBITDA | 175×— | —— | —— | —— | —— |
FAQ
- What are Journey Medical Corporation's profit margins?
- Journey Medical Corporation (DERM) runs a 65.5% gross margin and a -4.4% operating margin, with a -9.0% net margin.
- Where do Journey Medical Corporation's ratios come from?
- Every ratio is computed from Journey Medical Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
